[ad_1]
Bajaj Healthcare is trading at eye-catching valuations post the recent correction. While the stock has corrected meaningfully, the company’s business’s positives and negatives are well-balanced at current market valuations which are 11.6 times FY23 earnings. The company continues to show progress across multiple dimensions even though it ended FY22 on a mixed note. Moreover, with the company nearing the completion of its capex phase, it could see a gradual reduction in debt over FY23/24.
#stockpicks #MarketswithMoneycontrol #healthcare #revenue #valuations #earnings #BajajHealthcare #stockstobuy #stockstosell
Follow us:
Website: https://www.moneycontrol.com/
Facebook: https://www.facebook.com/moneycontrol/
Twitter: http://www.twitter.com/moneycontrolcom
Instagram: https://www.instagram.com/moneycontrolcom/
The post Bajaj Healthcare's Valuations Look Attractive Post Correction. Time To Buy? | Ideas For Profit appeared first on HumanitasConnects.
The post Bajaj Healthcare's Valuations Look Attractive Post Correction. Time To Buy? | Ideas For Profit appeared first on .
[ad_2]
Source link
